List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 206 studies with search of: "Tenofovir"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study to Compare Tenofovir Versus the Combination of Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B in Patients With Normal ALT
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: tenofovir disoproxil plus emtricitabine
2 Terminated ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Conditions: HBe Negative Chronic Hepatitis B;   Hepatitis B Viral Infection
Interventions: Drug: CLEVUDINE + TENOFOVIR PLACEBO;   Drug: CLEVUDINE IN ASSOCIATION TENOFOVIR;   Drug: TENOFOVIR + CLEVUDINE PLACEBO
3 Recruiting Tenofovir Disoproxil Fumarate (DF) Versus Emtricitabine/Tenofovir DF Fixed-Dose in Subjects Resistant to Lamivudine
Condition: Hepatitis B
Interventions: Drug: Tenofovir DF;   Drug: Emtricitabine/tenofovir DF
4 Not yet recruiting Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
5 Completed Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
Condition: HIV Infections
Interventions: Drug: Atazanavir+Ritonavir+Tenofovir;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine
6 Recruiting Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
7 Active, not recruiting A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: adefovir dipivoxil
8 Completed Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate;   Drug: Tenofovir DF placebo
9 Active, not recruiting A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: adefovir dipivoxil
10 Not yet recruiting Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo
11 Active, not recruiting Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease.
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: emtricitabine / tenofovir disoproxil fumarate;   Drug: entecavir
12 Active, not recruiting A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
Condition: Chronic Hepatitis B
Intervention: Drug: Tenofovir disoproxil fumarate
13 Recruiting Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Conditions: HIV-1 Infections;   HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF);   Drug: Placebo
14 Not yet recruiting Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
Condition: Chronic Hepatitis B
Interventions: Drug: telbivudine;   Drug: tenofovir disproxil fumarate;   Drug: telbivudine plus tenofovir disproxil fumarate
15 Active, not recruiting Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
Condition: HIV Infections
Interventions: Drug: Atazanavir + ritonavir + tenofovir + nucleoside;   Drug: Atazanavir + saquinavir + tenofovir + nucleoside;   Drug: Lopinavir/ritonavir + tenofovir + nucleoside
16 Recruiting A Single-Arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without Add-on Tenofovir in Adults With HBeAg-Positive Chronic Hepatitis B (CHB)
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir
17 Recruiting Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection
Condition: Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: placebo
18 Completed Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir DF + emtricitabine);   Drug: Emtriva (emtricitabine);   Drug: Viread (tenofovir DF)
19 Completed To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
Condition: HIV
Interventions: Drug: Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks;   Drug: Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks;   Drug: Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks
20 Active, not recruiting Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services